Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Stock Watcher's Thread / Pix of the Week (POW) -- Ignore unavailable to you. Want to Upgrade?

To: Stock Watcher who wrote (6801)	4/19/1999 8:05:00 PM
From: SteelerStu	Read Replies (1) \| Respond to of 52051

WASP -- Business Summary below: BACKGROUND: -- 14 year old company. -- "The products and medical therapies developed by this company represent the most important breakthrough in the field of Dermatology in the last fifty years." -- "Significant successes in the area of skin disease include: Cystic Acne, Eszema, Seborrhea, Contact Dermititis, Molluscum, Follicultis, Acne Rosacea, and less prevalent skin diseases." -- Wasatch is now on line with insurance providers independent of HMO's. Efforts to establish preferred providership status with HMO's is presently being pursued. -- American Institute of Skin Care, Inc, (AISC) is a wholly owned subsidiary of WASP. 3 currently in UTAH to grow to 350 nationwide in 5 years. -- In addition to the clinical products the company will be developing Over-The-Counter products. COMPETITION: -- "Competing products address the symptoms of acne and eczema and not the cause." -- "At this time there is no known competitor who treats the causes of these skin disorders and no competitor can claim a success rate equal to that of the AISC treatments." MARKETING: -- "To carry out our marketing strategies we will concentrate on a strong relationship with insurance health providers, media promotion of the clinics and OTC sales."